Through our deep and proven expertise within the neuroscience space and our dedicated expert team, HRW Synapse, we’ll help you improve the lives of patients with challenging and complex conditions and make your neuroscience assets a success.
Challenges in neuroscience can include:
• Forecasting usage of novel, pipeline products with new modes of action within underserved spaces
• Connecting with vulnerable patients with psychiatric or neurodegenerative disorders
• Differentiating within a congested market with complicated prescribing pattern
Achieving your objectives with often complex respondent groups – be they healthcare professionals, patients or carers – within the fast-evolving neuroscience market isn’t easy.
Neurodegenerative and psychiatric disorders are challenging to treat. Few conditions have a ‘one size fits all’ solution, with holistic care, personalised treatment options and the patient environment playing a significant role.
As neuroscience specialists, we’ll bring our expertise to your project to ensure the idiosyncrasies of your therapy area are at the forefront of your research design and interpretation.
Together, we equip you with an extensive suite of tools to use within your projects and we understand how these must be adapted for neuroscience to ensure they are appropriate and manageable.
So, we can provide you with the holistic expertise and consultancy within neuroscience you require and uncover the insights you need.
Abigail has worked on a plethora of mental health conditions and has deep knowledge in bipolar disorder, schizophrenia. She also has knowledge of upcoming treatments, including researching into the use of psychedelics and has experience working in depression and Parkinson's Disease.
Alex has a PhD in Neuroscience with a focus in Alzheimer's disease. Alex is part of our in-house behavioural science team, HRW Shift, and loves to combine her experience in neurology with her knowledge of behavioural science.
Cathy heads up the Synapse team giving direction and spearheading the initiative across the company. She has embedded knowledge across an array of conditions including, Bipolar disorder, Borderline Personality disorder, PTSD, depression and schizophrenia.
Dana has a passion for market research within neuroscience and psychiatry, and has recently gained experience working on novel and pipeline psychedelics for the treatment of TRD (treatment resistance depression) and alcohol use disorder.
Esme collaborates with Cathy in spearheading the Synapse team. Esme has a BSc Hons in psychology and a keen interest in understanding client business needs and how to partner with clients to maximise their strategic and commercial success.
Faye is a research director and brings experience across a number of neurological conditions. This includes extensive knowledge on schizophrenia, PTSD and BoPD as well as Parkinson's Disease, Agitation in Alzheimer’s and Migraines.
Vincent brings a wealth of neurology expertise. Having studied diseases of the nervous system as a major his experience including schizophrenia, rare neurological conditions and multiple sclerosis.
Lucy was diagnosed with chronic migraines in 2018 and since then has been an online advocate in the migraine space. She is an online influencer with a blog reaching over 1,000 people and has her finger on the pulse in terms of latest developments.
Rhiannon has a wealth of knowledge in the mental health space which includes schizophrenia, PTSD and BoPD. Rhiannon has worked in the forefront of new assets and as part of HRW SHIFT combines her learnings with a behavioural science lens.
Rifah recently gradated with a degree in Neuroscience where she focused on the reward pathways in the brain which surround addiction and ADHD. Rifah has also conducted her own research exploring differences in maternal and paternal brain shape and language acquisitions in infants. Rifah is fascinated by different neurological conditions and is always researching the latest research across different therapies.
Millie recently graduated from University College London where her MSci degree explored the impact of a variety of neurological and mental disorders, including chronic pain and general anxiety disorder (GAD). Throughout her studies, Millie also gained a deep understanding of Alzheimer’s Dementia and various forms of Amnesia to Schizophrenia. Beyond research, Millie is focused on ‘de-bunking’ some of the stigma that surrounds mental health and wider society seeing ‘physical’ and ‘mental’ health as two separate entities.
Our client was preparing for the launch of their treatment for Agitation in Alzheimer’s Disease (AAD), for which they needed:
Insights from this research were used to inform a global positioning, but also understand the local nuances.
We conducted a multi-phase qualitative into qualitative project in EU5 markets with GPs, neurologists and psychiatrists
Behavioural science re-analysis of existing research: HRW Shift reviewed our client’s existing market research reports to identify underlying mechanisms behind behaviour and inform the design of subsequent research accordingly.
QualieTM Customer survey:
Lexicon analysis: linguistic analysis of the spontaneous language used by respondents (qual) and validated as impactful (quant) to provide guidance one how to speak to HCPs about ketogenic diet as a viable option for treatment.
Blogs, News, and Insights
Ageing and the Brain: Could Ageing be a Disease?
Ageing is thought to be our inevitable fate – an accumulation of wisdom, as well as mutations that reside in our DNA w...
Boys Don’t Cry: The Impact of Gender Norms Within Psychiatry
Think back to the last time that you took a sick day – at what moment did you become certain that you were ill? Was th...
Complexities of Chronic Pain: How Do You Believe It and Treat It, If You Can’t See It?
Pain, while unpleasant, is a crucial component of our survival. Without pain, we would have no motivat...
The Patient Voice in Major Depressive Disorder (MDD): Social Media Listening vs. Google Trends Analysis
Here at HRW we love to seek out the most innovative methodologies and ‘stress test’ them to ensure robustness in dat...
A Patient Segmentation: A Slightly Alternative Methodology
Providing our clients with robust and actionable segmentations forms the cornerstone of HRW: after all, our sister compa...
Neuroscience KOL Expert Panel: Your Questions Answered
Interested in learning about the future neuroscience landscape?
Our clients have submitted their burning innovation a...
The Future of Psychiatry? A debate on Psychedelic and Dissociative Treatments
In recent years, the ‘noise’ around the use of psychedelics and dissociatives to treat different neurologica...
Information In – Influence Out
Imagine being newly diagnosed with a condition and the distressing realisation that there is little information availabl...
Episode 2: Spotlight on Alzheimer’s Day: Insights from Research
This year, as part of World Azheimer’s Day, Alexandra Petrache, Senior Behavioural Science Analyst and valued member o...
Episode 1: Into The Spotlight
Migraines are actually a debilitating neurological disease, and although they are seen as a common headache disorder, th...
checkedI would like to receive news and information from HRW
© Copyright HRW 2023
Designed in the UK by Yellowball.